Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content

被引:0
作者
Cooper, MB [1 ]
Tan, KCB [1 ]
Hales, CN [1 ]
Betteridge, DJ [1 ]
机构
[1] UCL, SCH MED, DEPT MED, LONDON W1N 8AA, ENGLAND
关键词
diabetes; hypertriglyceridaemia; insulin secretion; postprandial lipoprotein metabolism;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postprandial lipid profiles and release of insulin (INS), intact proinsulin (PI), and 32-33 split proinsulin (SPI) in response to a mixed meal with a high fat content were determined over a 12 h period in non-obese control subjects (n=10) and non-insulin-dependent (Type 2) diabetic (NIDDM) patients with normotriglyceridaemia (NTG; n=11) and hypertriglyceridaemia (HTG; n=10), bu calculation of th 'areas under the curves' (AUC). The postprandial triglyceride-AUC was significantly greater in HTG-NIDDM patients (p<0.05) than in NTG-NIDDM or control subjects. Chylomicron clearance was impaired only in HTG-NIDDM patients (p <0.05). Chylomicron-remnant clearance was impaired in both groups of NIDDM patients (p <0.05). The postprandial suppression of plasma non-esterified fatty acid (NEFA) content was impaired in HTG-NIDDM patients (p <0.05). The postprandial INS-, PI and SPI-AUCS were significantly greater than in the control subjects (p <0.05). In NIDDM, triglyceride-AUC correlated significantly with PI and SPI release (triglyceride-AUC vs PI, p <0.05; triglyceride-AUC vs INS, p=NS; chylomicron-remnant-AUC vs PI, p <0.01; chylomicron-remnant-AUC vs SPI, p <0.01). The NEFA response was associated with fasting plasma SPI content (NEFA-AUC vs SPI, p<0.05). Postprandial chylomicron AUC was not related to the overall secretion of INS, PI or SPI. However, triglyceride-, chylomicron-remnant- and NEFA-AUCS were all associated positively with the release of PI and SPI (p <0.05). In multivariate analyses, chylomicron-remnant clearance had the major relationship with the release of insulin precursors, accounting for 23% of the variability (p <0.01). Inclusion of overall response of free fatty acids improved the model, with both parameters together accounting for 30% of the variability (p <0.01). The output of the beta-cell over the postprandial period differed between the NIDDM patients and the control subjects in that when glycaemic stimulation was moderate, the proportion of insulin-like molecules as a percentage of the total output was greater than in control subjects but this was not the situation when glycaemia was greatest. We conclude that abnormal postprandial lipaemia in NIDDM is associated with beta-cell output, possibly mediated by the availability of free fatty acids.
引用
收藏
页码:816 / 827
页数:12
相关论文
共 46 条
  • [21] Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)
    Lee, Clare J.
    Mao, Huzhang
    Thieu, Vivian T.
    Lando, Laura Fernandez
    Thomas, Melissa K.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (05)
  • [22] PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naive type 2 diabetes mellitus patients
    Liu, Xu
    Song, Ling
    Zhang, Yuanhui
    Li, Haiyan
    Cui, Cheng
    Liu, Dongyang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [23] Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with Type 2 diabetes mellitus
    Laing, I
    Olukoga, AO
    Gordon, C
    Boulton, AJM
    DIABETIC MEDICINE, 1998, 15 (06) : 473 - 479
  • [24] Evaluation of Beta Cell Dysfunction by Mixed Meal Tolerance Test and Oral L-arginine in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Ozbek, M.
    Erdogan, M.
    Karadeniz, M.
    Cetinkalp, S.
    Ozgen, A. G.
    Saygili, F.
    Yilmaz, C.
    Tuzun, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (10) : 573 - 576
  • [25] Disruption of estrogen-regulated gene expression by dioxin: downregulation of a gene associated with the onset of non-insulin-dependent diabetes mellitus (type 2 diabetes)
    Hokanson, R
    Miller, S
    Hennessey, M
    Flesher, M
    Hanneman, W
    Busbee, D
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2004, 23 (12) : 555 - 564
  • [26] Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes
    Qujeq, Durdi
    Mahrooz, Abdolkarim
    Alizadeh, Ahad
    Boorank, Ruzbeh
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
  • [27] Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes
    Thamer, C.
    Haap, M.
    Heller, E.
    Joel, L.
    Braun, S.
    Tschritter, O.
    Haring, H.
    Fritsche, A.
    HORMONE AND METABOLIC RESEARCH, 2006, 38 (03) : 178 - 182
  • [28] Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics
    Jasik, M
    KasperskaDworak, A
    Czyzyk, A
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1996, 33 (01) : 59 - 66
  • [29] Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study
    Ghasemi, Asghar
    Tohidi, Maryam
    Derakhshan, Arash
    Hasheminia, Mitra
    Azizi, Fereidoun
    Hadaegh, Farzad
    ACTA DIABETOLOGICA, 2015, 52 (05) : 905 - 915
  • [30] Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?
    Veelen, Anna
    Erazo-Tapia, Edmundo
    Oscarsson, Jan
    Schrauwen, Patrick
    MOLECULAR METABOLISM, 2020, 46